RxSight, Inc. – NASDAQ:RXST
RxSight stock price today
$8.6
-25.61
-74.87%
Financial Health
0
1
2
3
4
5
6
7
8
9
Market closed
Open in about 6 hours
RxSight stock price monthly change
-28.29%
month
RxSight stock price quarterly change
-28.29%
quarter
RxSight stock price yearly change
-16.33%
year
RxSight key metrics
Market Cap | 1.38B |
Enterprise value | 469.88M |
P/E | -7.31 |
EV/Sales | 9.58 |
EV/EBITDA | -8.13 |
Price/Sales | 9.73 |
Price/Book | 5.30 |
PEG ratio | -1.04 |
EPS | -1.26 |
Revenue | 109.56M |
EBITDA | -41.04M |
Income | -44.49M |
Revenue Q/Q | 68.74% |
Revenue Y/Y | 90.38% |
Profit margin | -136.22% |
Oper. margin | -129.21% |
Gross margin | 43.52% |
EBIT margin | -129.21% |
EBITDA margin | -37.46% |
Sign up &
create your own Smart Feed
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeRxSight stock price history
RxSight stock forecast
RxSight financial statements
Average Price Target
$68.13
Potential upside: 692.15%
Analysts Price target
Financials & Ratios estimates
| Jun 2023 | 20.81M | -13.80M | -66.33% |
|---|---|---|---|
| Sep 2023 | 30.66M | -12.41M | -40.48% |
| Dec 2023 | 28.58M | -9.17M | -32.11% |
| Mar 2024 | 29.51M | -9.1M | -30.83% |
| 2024-02-28 | -0.36 | -0.26 |
|---|---|---|
| 2024-05-06 | -0.17 | -0.12 |
| Jun 2023 | 195261000 | 38.07M | 19.5% |
|---|---|---|---|
| Sep 2023 | 181850000 | 20.37M | 11.2% |
| Dec 2023 | 182550000 | 22.18M | 12.15% |
| Mar 2024 | 183165000 | 19.23M | 10.5% |
| Jun 2023 | -7.54M | 4.39M | 891K |
|---|---|---|---|
| Sep 2023 | -7.98M | 17.27M | -8.23M |
| Dec 2023 | -9.88M | 4.56M | 5.15M |
| Mar 2024 | -9.30M | 24.27M | 7.99M |
RxSight alternative data
| Aug 2023 | 292 |
|---|---|
| Sep 2023 | 292 |
| Oct 2023 | 292 |
| Nov 2023 | 292 |
| Dec 2023 | 292 |
| Jan 2024 | 292 |
| Feb 2024 | 292 |
| Mar 2024 | 374 |
| Apr 2024 | 374 |
| May 2024 | 374 |
| Jun 2024 | 374 |
| Jul 2024 | 374 |
RxSight other data
25.48%
-9.26%
of RXST is owned by hedge funds
42
-14
7.04M
-2.56M
shares is hold by hedge funds
What is insider trading?
| Period | Buy | Sel |
|---|---|---|
| Dec 2023 | 0 | 160437 |
| Jan 2024 | 0 | 197839 |
| Feb 2024 | 8000 | 105744 |
| Mar 2024 | 0 | 10000 |
| Apr 2024 | 0 | 20000 |
| May 2024 | 5000 | 50000 |
| Jun 2024 | 0 | 15625 |
| Jul 2024 | 0 | 18402 |
| Aug 2024 | 0 | 9000 |
| Sep 2024 | 0 | 15505 |
| Oct 2024 | 0 | 49115 |
| Nov 2024 | 22476 | 28592 |
| Quarter | Transcript |
|---|---|
| Q1 2024 6 May 2024 | Q1 2024 Earnings Call Transcript |
| Q4 2023 28 Feb 2024 | Q4 2023 Earnings Call Transcript |
| Q3 2023 12 Nov 2023 | Q3 2023 Earnings Call Transcript |
| Q2 2023 7 Aug 2023 | Q2 2023 Earnings Call Transcript |
| Insider | Compensation |
|---|---|
Dr. Ronald M. Kurtz M.D. (1963) Pres, Chief Executive Officer & Director | $336,580 |
Dr. Ilya Goldshleger Ph.D. (1975) Chief Operating Officer | $332,090 |
Mr. Eric J. Weinberg (1961) Chief Commercial Officer | $317,600 |
| Ms. Shelley B. Thunen (1954) Chief Financial Officer & Assistant Sec. | $295,510 |
-
What's the price of RxSight stock today?
One share of RxSight stock can currently be purchased for approximately $8.6.
-
When is RxSight's next earnings date?
Unfortunately, RxSight's (RXST) next earnings date is currently unknown.
-
Does RxSight pay dividends?
No, RxSight does not pay dividends.
-
How much money does RxSight make?
RxSight has a market capitalization of 1.38B and it's past years’ income statements indicate that its last revenue has increased compared to the previous period by 81.77% to 89.08M US dollars. RxSight made a loss 48.61M US dollars in net income (profit) last year or -$0.12 on an earnings per share basis.
-
What is RxSight's stock symbol?
RxSight, Inc. is traded on the NASDAQ under the ticker symbol "RXST".
-
What is RxSight's primary industry?
Company operates in the Healthcare sector and Medical - Devices industry.
-
How do i buy shares of RxSight?
Shares of RxSight can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
Who are RxSight's key executives?
RxSight's management team includes the following people:
- Dr. Ronald M. Kurtz M.D. Pres, Chief Executive Officer & Director(age: 62, pay: $336,580)
- Dr. Ilya Goldshleger Ph.D. Chief Operating Officer(age: 50, pay: $332,090)
- Mr. Eric J. Weinberg Chief Commercial Officer(age: 64, pay: $317,600)
- Ms. Shelley B. Thunen Chief Financial Officer & Assistant Sec.(age: 71, pay: $295,510)
-
How many employees does RxSight have?
As Jul 2024, RxSight employs 374 workers.
-
When RxSight went public?
RxSight, Inc. is publicly traded company for more then 4 years since IPO on 30 Jul 2021.
-
What is RxSight's official website?
The official website for RxSight is rxsight.com.
-
Where are RxSight's headquarters?
RxSight is headquartered at 100 Columbia, Aliso Viejo, CA.
-
How can i contact RxSight?
RxSight's mailing address is 100 Columbia, Aliso Viejo, CA and company can be reached via phone at +94 95217830.
-
What is RxSight stock forecast & price target?
Based on 7 Wall Street analysts` predicted price targets for RxSight in the last 12 months, the avarage price target is $68.13. The average price target represents a 692.15% change from the last price of $8.6.
RxSight company profile:
RxSight, Inc.
rxsight.comExchange:
NASDAQ
Full time employees:
374
Industry:
Medical - Devices
Sector:
Healthcare
RxSight, Inc., a medical technology company, engages in the research and development, manufacture, and sale of light adjustable intraocular lenses (LAL) used in cataract surgery in the United States and internationally. It offers RxSight system that enables doctors to customize and enhance the visual acuity for patients after cataract surgery. The company's RxSight system includes RxSight light delivery device, an office-based light treatment device that delivers UV light in a programmed pattern to modify the LAL based on the visual correction needed to achieve desired vision after cataract surgery. It primarily serves cataract doctors. The company was formerly known as Calhoun Vision, Inc. and changed its name to RxSight, Inc. in February 2017. RxSight, Inc. was incorporated in 1997 and is headquartered in Aliso Viejo, California.
100 Columbia
Aliso Viejo, CA 92656
Aliso Viejo, CA 92656
CIK: 0001111485
ISIN: US78349D1072
CUSIP: 78349D107
